{
  "title": "Table 1 Baseline characteristics by treatment group",
  "source": "Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial",
  "data": [
    {
      "section": "Clinical",
      "row_header": "No. of participants",
      "column_header": "Placebo",
      "value": "20"
    },
    {
      "section": "Clinical",
      "row_header": "No. of participants",
      "column_header": "Semaglutide",
      "value": "20"
    },
    {
      "section": "Clinical",
      "row_header": "No. of participants",
      "column_header": "Empagliflozin",
      "value": "20"
    },
    {
      "section": "Clinical",
      "row_header": "No. of participants",
      "column_header": "Combination",
      "value": "20"
    },
    {
      "section": "Clinical",
      "row_header": "No. of participants",
      "column_header": "p value",
      "value": "–"
    },
    {
      "section": "Clinical",
      "row_header": "Age, years",
      "column_header": "Placebo",
      "value": "64.6 ± 6.1"
    },
    {
      "section": "Clinical",
      "row_header": "Age, years",
      "column_header": "Semaglutide",
      "value": "70.1 ± 6.8"
    },
    {
      "section": "Clinical",
      "row_header": "Age, years",
      "column_header": "Empagliflozin",
      "value": "69.6 ± 6.0"
    },
    {
      "section": "Clinical",
      "row_header": "Age, years",
      "column_header": "Combination",
      "value": "67.9 ± 6.2"
    },
    {
      "section": "Clinical",
      "row_header": "Age, years",
      "column_header": "p value",
      "value": "0.03"
    },
    {
      "section": "Clinical",
      "row_header": "Male sex",
      "column_header": "Placebo",
      "value": "14 (70)"
    },
    {
      "section": "Clinical",
      "row_header": "Male sex",
      "column_header": "Semaglutide",
      "value": "17 (85)"
    },
    {
      "section": "Clinical",
      "row_header": "Male sex",
      "column_header": "Empagliflozin",
      "value": "13 (65)"
    },
    {
      "section": "Clinical",
      "row_header": "Male sex",
      "column_header": "Combination",
      "value": "17 (85)"
    },
    {
      "section": "Clinical",
      "row_header": "Male sex",
      "column_header": "p value",
      "value": "0.32"
    },
    {
      "section": "Biochemistry",
      "row_header": "HbA1c, mmol/mol",
      "column_header": "Placebo",
      "value": "60 (51–67)"
    },
    {
      "section": "Biochemistry",
      "row_header": "HbA1c, mmol/mol",
      "column_header": "Semaglutide",
      "value": "59 (52–62)"
    },
    {
      "section": "Biochemistry",
      "row_header": "HbA1c, mmol/mol",
      "column_header": "Empagliflozin",
      "value": "57 (52–60)"
    },
    {
      "section": "Biochemistry",
      "row_header": "HbA1c, mmol/mol",
      "column_header": "Combination",
      "value": "58 (50–74)"
    },
    {
      "section": "Biochemistry",
      "row_header": "HbA1c, mmol/mol",
      "column_header": "p value",
      "value": "0.85"
    },
    {
      "section": "Medication",
      "row_header": "Metformin",
      "column_header": "Placebo",
      "value": "18 (90)"
    },
    {
      "section": "Medication",
      "row_header": "Metformin",
      "column_header": "Semaglutide",
      "value": "17 (85)"
    },
    {
      "section": "Medication",
      "row_header": "Metformin",
      "column_header": "Empagliflozin",
      "value": "18 (90)"
    },
    {
      "section": "Medication",
      "row_header": "Metformin",
      "column_header": "Combination",
      "value": "20 (100)"
    },
    {
      "section": "Medication",
      "row_header": "Metformin",
      "column_header": "p value",
      "value": "0.40"
    }
  ]
}
